CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE

被引：0
|
作者：
Frascaro, F. [1 ]
Pavasini, R. [1 ]
Marchini, F. [1 ]
Bianchi, N. [1 ]
Zanarelli, L. [1 ]
Sanguettoli, F. [1 ]
Meossi, S. [1 ]
Guardigli, G. [1 ]
机构：
[1] Azienda Osped Univ St Anna, Ferrara, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P422
引用
收藏
页码：D211 / D211
页数：1
相关论文
共 50 条
  • [41] Clinical characteristics and prognosis of pancreatitis associated with immune checkpoint inhibitors
    Zhang, Junzi
    Jiang, Xianzhuo
    Liu, Ning
    Qi, Zhaoxue
    Mi, Xuguang
    Fang, Yanqiu
    Zhang, Wenqi
    Yang, Zhen
    Ou, Wenjie
    Lin, Xiuying
    Hou, Junjie
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 333 - 339
  • [42] A Systematic Review of Myocarditis Induced by Immune Checkpoint Inhibitors: How Concerning Is the Most Common Cardiotoxicity of Immune Checkpoint Inhibitors?
    Moradi, Ali
    Kodali, Athri
    Okoye, Chiugo
    Klein, Dhadon Hannah
    Mohamoud, Iman
    Olanisa, Olawale O.
    Parab, Panah
    Chaudhary, Priti
    Mukhtar, Sonia
    Mohammed, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [43] Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
    Annamaria Mascolo
    Cristina Scavone
    Carmen Ferrajolo
    Concetta Rafaniello
    Romano Danesi
    Marzia Del Re
    Antonio Russo
    Enrico Coscioni
    Francesco Rossi
    Roberto Alfano
    Annalisa Capuano
    Drug Safety, 2021, 44 : 957 - 971
  • [44] Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
    Mascolo, Annamaria
    Scavone, Cristina
    Ferrajolo, Carmen
    Rafaniello, Concetta
    Danesi, Romano
    Del Re, Marzia
    Russo, Antonio
    Coscioni, Enrico
    Rossi, Francesco
    Alfano, Roberto
    Capuano, Annalisa
    DRUG SAFETY, 2021, 44 (09) : 957 - 971
  • [45] Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
    Totzeck, Matthias
    Lutgens, Esther
    Neilan, Tomas G.
    EUROPEAN HEART JOURNAL, 2021, 42 (16) : 1632 - 1635
  • [46] Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors
    Franco, F. F.
    Garitaonaindia, Y.
    Blanco Clemente, M.
    Torrente, M.
    Calvo de Juan, V.
    Collazo Lorduy, A.
    Gutierrez, L.
    Sanchez, J. C.
    del Alba Baamonde, M. A. Gonzalez
    Royuela, A.
    Visedo, G.
    Gonzalez, S. C.
    Martinez Cutillas, M.
    Traseira Puchol, C.
    Aguado, R.
    Mitroi, C. D.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1406 - S1406
  • [47] Case Report: Cardiac Toxicity Associated With Immune Checkpoint Inhibitors
    Chen, Ru
    Peng, Ling
    Qiu, Zhihua
    Wang, Yan
    Wei, Fen
    Zhou, Min
    Zhu, Feng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [48] Endocrinopathies Related to Immune Checkpoint Inhibitors: A Clinical Case Report
    de Castro, Matilde Jacome
    Verissimo, David
    Marcelino, Mafalda
    de Castro, Joao Jacome
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2020, 15 (3-4) : 185 - 189
  • [49] Immune Checkpoint Inhibitors Associated with Cardiotoxicity in Cancer Patients: A Large Single-Center Experience
    Chahine, Johnny
    Thapa, Bicky
    Ala, Chandra K.
    Patil, Pradnya
    Funchain, Pauline
    Maroo, Anjli
    Klein, Allan L.
    Tang, W. H. Wilson
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S63 - S63
  • [50] A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety
    Rubio-Infante, Nestor
    Ramirez-Flores, Yoel Adbel
    Castillo, Elena Cristina
    Lozano, Omar
    Garcia-Rivas, Gerardo
    Torre-Amione, Guillermo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
12345